4//SEC Filing
LeBel Carl 4
Accession 0001127602-22-005750
CIK 0001703647other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:12 PM ET
Size
9.2 KB
Accession
0001127602-22-005750
Insider Transaction Report
Form 4
LeBel Carl
Chief Development Officer
Transactions
- Sale
Common Stock
2022-02-17$4.19/sh−901$3,774→ 13,169 total - Award
Restricted Stock Unit
2022-02-17+150,000→ 150,000 total→ Common Stock (150,000 underlying) - Sale
Common Stock
2022-02-16$4.43/sh−831$3,680→ 14,070 total
Footnotes (5)
- [F1]Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.29 to $4.54. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.00 to $4.50. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F5]The restricted stock units will fully vest on July 4, 2023.
Documents
Issuer
Frequency Therapeutics, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001439275
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 4:12 PM ET
- Size
- 9.2 KB